Zheng Yu Yuan
Fondateur chez MicuRx Pharmaceuticals, Inc.
Profil
Zheng Yu Yuan is the founder of MicuRx Pharmaceuticals, Inc. where he currently holds the title of President, Chief Executive Officer & Director since 2008.
He is also the founder of Shanghai MicuRx Pharmaceutical Co., Ltd.
where he currently holds the title of Chairman & General Manager since 2012.
Dr. Yuan is also the founder of Vicuron Pharmaceuticals LLC.
Dr. Yuan's former job positions include being a Principal at Affymax, Inc., GlaxoWellcome, and Syntex Chemicals, Inc. In terms of education, Dr. Yuan received a doctorate degree from Cornell University in 1988 and an undergraduate degree from Fudan University in 1982.
Postes actifs de Zheng Yu Yuan
Sociétés | Poste | Début |
---|---|---|
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Fondateur | 01/03/2007 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | Directeur Général | 07/08/2012 |
Anciens postes connus de Zheng Yu Yuan
Sociétés | Poste | Fin |
---|---|---|
GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - |
Syntex Chemicals, Inc. | Corporate Officer/Principal | - |
AFFYMAX, INC. | Corporate Officer/Principal | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Fondateur | - |
Formation de Zheng Yu Yuan
Cornell University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AFFYMAX, INC. | Health Technology |
Health Technology |
Entreprise privées | 4 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
Syntex Chemicals, Inc. |